Menu Close

Study identifies therapeutic target for Alzheimer’s disease, revealing strategy for slowing disease progression

About 11% of the U.S. population 65 and older has been diagnosed with Alzheimer’s disease (AD), the most common form of dementia that results in memory loss and cognitive impairment, according to the Alzheimer’s Association.

Generated by Feedzy